Summary
By the early 1980s, perioperative prophylaxis in vaginal hysterectomy had been shown consistently to be of such value in reducing postoperative infection that some authors maintained that further placebo-controlled studies were no longer ethical. The benefit of prophylaxis in abdominai hysterectomy was less uniformly demonstrated, in studies which were prospective, placebo-controlled, double-blind and randomised. Prophylaxis may significantly reduce the incidence of febrile morbidity and/or wound/pelvic infection, the duration of hospital stay, or the total usage of antibiotics. It is therefore generally agreed that each centre should itself scientifically evaluate the efficacy of prophylaxis before a decision on its routine use in abdominal hysterectomy is made. In comparative studies, agents which were active against both anaerobic and aerobic organisms were more efficacious than those active against anaerobes only. Antibiotics with similar spectra of activity showed similar efficacy in both types of hysterectomy. Multiple- and single-dose regimens of the same antibiotics also showed equal efficacy. The new cephalosporins with a longer half-life were attractive theoretically as agents in single-dose regimens; ceftriaxone, however, has been shown to have an adverse effect on the normal gut flora
With the increased numbers of induced abortions carried out in the UK and other parts of the world in recent years, the need to reduce postabortal infection is generally appreciated. The results of early studies using tetracyclines as the prophylactic agents were difficult to evaluate because of the incomplete follow-up and different definitions of pelvic infections. No benefit was demonstrated in 2 studies using a single preoperative dose of tinidazole, whereas oral metronidazole in 3 doses and penicillin/pivampicillin for 4 days were shown to be efficacious in reducing postabortal infection. In a recent study with doxycycline, significant benefit was shown in patients with negative preoperative screening for gonococcal and chlam ydial infection. These genital infections, together with a history of previous pelvic inflammatory disease (PID)/gonorrhoea, nulliparity with multiple partners, young age of the patient and gestational age have been described as significant risk factors. Some researchers hold the view that selective prophylaxis based on these risk factors should be practised instead of mass prophylaxis. All agree that an antibiotic regimen that is both efficacious and well tolerated has yet to be found
Similar content being viewed by others
References
Allen J, Rampone JF, Wheeless C. Use of a prophylactic antibiotic in elective major gynecologic operations. Obstetrics and Gynecology 39: 218–224, 1972
Amirikia H, Evans T. Ten-year review of hysterectomies: trends, indications and risks. American Journal of Obstetrics and Gynecology 134: 431–437, 1979
Barlett JG, Moon ME, Goldstein PR, Goren B, Onderdonk AB, et al. Cervical and vaginal bacterial flora; ecologic niches in the female lower genital tract. American Journal of Obstetrics and Gynecology 130: 658–661, 1978
Barlett JG, Onderdonk AB, Drude E, Goldstein C, Anderka M, et al. Quantitative bacteriology of the vaginal flora. Journal of Infectious Diseases 136: 271–277, 1977
Berger S, Nager H, Myron G. Antimicrobial prophylaxis in obstetric and gynecologic surgery: a critical review. Journal of Reproductive Medicine 24: 185–190, 1980
Berkeley AS, Freedman KS, Ledger WJ. Comparison of cefotetan and cefoxitin prophylaxis for abdominal and vaginal hysterectomy. American Journal of Obstetrics and Gynecology 158: 706–709, 1988a
Berkeley AS, Orr JW, Cavanagh D, Freeman KS, Ledger WJ, et al. Comparative effectiveness and safety of cefotetan and cefoxitin as prophylactic agents in patients undergoing abdominal or vaginal hysterectomy. American Journal of Surgery 155: 81–85, 1988b
Brautigam HH, Knothe H, Rangoonwala R. Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy. Drugs 35: 163–168, 1988
Brewer C. Prevention of infection after abortion with a supervised single dose of oral doxycycline. British Medical Journal 281: 781, 1980
Brown EM, Depares J, Robertson AA, Jones S, Hughes A, et al. Amoxycillin-clavulanic acid (Augmentin) versus metronidazole as prophylaxis in hysterectomy: a prospective randomized clinical trial. British Journal of Obstetrics and Gynaecology 95: 286–293, 1988
Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50: 161–168, 1961
Burke JF. Preoperative antibiotics. Surgery Clinics of North America 43: 665–676, 1963
Burkman R, Atienza MF, King TM. Culture and treatment results in endometritis following elective abortion. American Journal of Obstetrics and Gynecology 128: 556–559, 1977
Chodak GW, Plaut ME. Use of systemic antibiotics for prophylaxis in surgery. Archives of Surgery 112: 326–334, 1977
Crombleholme WR. Use of prophylactic antibiotics in obstetrics and gynecology. Clinical Obstetrics and Gynecology 31(2): 466–472, 1988
Davey PG, Duncan ID, Edwards D, Scott AC. Cost benefit analysis of cephradine and mezlocillin prophylaxis for abdominal and vaginal hysterectomy. British Journal of Obstetrics and Gynaecology 95: 1170–1177, 1988
Duerden BI. The isolation and identification of Bacteroides spp. from the normal human vaginal flora. Journal of Medical Microbiology 13: 79–87, 1980
Duff P. Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics and Gynecology 60: 25–29, 1982
Duff P, Park RC. Antibiotic prophylaxis in vaginal hysterectomy: a review. Obstetrics and Gynecology 55: 113S-202S, 1980
Elek SD. Experimental staphylococcal infections in the skin of man. Annals of the New York Academy of Sciences 65: 85–90, 1956
Eron IJ, Gordon SJ, Harvey LK, Sites JG. A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. DICP 23(9): 655–658, 1989
Freiman JA, Chalmers TC, Smith H, Kuebler RR. The importance of beta, the type 11 error and sample size in the design and interpretation of the randomized control trial. New England Journal of Medicine 299: 690–694, 1978
Friese S, Willems FT, Loriaux SM, Meewis JM. Prophylaxis in gynaecological surgery: a prospective randomised comparison between single dose prophylaxis with amoxycillin/clavulanate and the combination of cefuroxime and metronidazole. Journal of Antimicrobial Agents and Chemotherapy 24 (B): 213–216, 1989
Galle PC, Urban RB, Homesley HD, Jobson VW, Scott-Wheeler A. Single dose carbenicillin versus T-tube drainage in patients undergoing vaginal hysterectomy. Surgery, Gynecology and Obstetrics 153: 351–352, 1981
Garibaldi RA, Burke JP, Dickman ML, Smith CB. Factors predisposing to bacteriuria during indwelling uretheral catheterisation. New England Journal of Medicine 291: 215–219, 1974
Giles JA, Ashe A, Heap J, Hey F, Moloney M, et al. A prospective controlled trial of cephradine and metronidazole as prophylaxis with abdominal hysterectomy. Journal of Obstetrics and Gynaecology 5: S13–S17, 1984
Goosenberg J. Prophylactic antibiotics in vaginal hysterectomy. American Journal of Obstetrics and Gynecology 105: 503–506, 1969
Gordon SF. Results of a single-centre study of cefotetan prophylaxis in abdominal or vaginal hysterectomy. American Journal of Obstetrics and Gynecology 158: 710–714, 1988
Grimes DA, Schulz KF, Cates W. Prophylactic antibiotics for curettage abortion. American Journal of Obstetrics and Gynecology 150: 689–694, 1984
Grossman III J. Prophylactic antibiotics in gynecologic surgery. Obstetrics and Gynecology 53: 537–544, 1979
Hamod K, Spence M, Rosenshein N, Dillon M. Single-dose and multi-dose in vaginal hysterectomy: a comparison of sodium cephalothin and metronidazole. American Journal of Obstetrics and Gynecology 136: 976–979, 1980
Hamod KA, Spence MR, King TM. Prophylactic antibiotics in vaginal hysterectomy: a review. Obstetrical and Gynaecological Survey 37: 207–210, 1982
Heisterberg L, Hebjorn S, Andersen L, Petersen H. Sequelae of induced first-trimester abortion: a prospective study assessing the role of postabortal pelvic inflammatory disease and prophylactic antibiotic. American Journal of Obstetrics and Gynecology 155: 76–80, 1986
Heisterberg L, Petersen K. Metronidazole prophylaxis in elective first trimester abortion. Obstetrics and Gynecology 65: 371–374, 1985
Helm C, Houang E, McDonald C. Bacterial contamination during abdominal hysterectomy. Journal of Obstetrics and Gynecology 6: 64–66, 1986
Hemsell D, Bawdon RE, Hemsell P, Nobles B, Johnson E, et al. Single-dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy. Journal of Obstetrics and Gynaecology 156: 1201–1205, 1987a
Hemsell D, Heard M, Nobles B, Bawdon R, Hemsell P. Single-dose prophylaxis for vaginal and abdominal hysterectomy. American Journal of Obstetrics and Gynecology 157: 498–501, 1987b
Hemsell D, Heard M, Nobles B, Hemsell P. Single dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics and Gynecology 63: 285–290, 1984a
Hemsell D, Hemsell P, Nobles B, Heard M, Bawdon R. Moxalactam versus cefazolin prophylaxis for vaginal hysterectomy. American Journal of Obstetrics and Gynecology 147: 379–385, 1983a
Hemsell D, Johnson E, Bawdon R, Hemsell P, Heard M, et al. Cefoperazone and cefoxitin prophylaxis for abdominal hysterectomy. Obstetrics and Gynecology 63: 467–472, 1984b
Hemsell DL, Menon MO, Freidman AJ. Ceftriaxone or cefazolin prophylaxis for the prevention of infection after vaginal hysterectomy. American Journal of Surgery 148: 22–26, 1984c
Hemsell D, Reisch J, Nobles B, Hemsell P. Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics and Gynecology 147: 520–528, 1983b
Hirsch H. Prophylactic antibiotics in obstetrics and gynecology. American Journal of Medicine 78(6B): 170–176, 1985
Hirshmann JV, Inui TS. Antimicrobial prophylaxis: a critique of recent trials. Reviews of Infectious Diseases 2: 1–23, 1980
Hodgson JE, Major B, Portmann K, Quattlebaum FW. Prophylactic use of tetracycline for first trimester abortions. Obstetrics and Gynecology 45: 574–578, 1975
Hogue CJR, Teitze C, Cates W. The effects of induced abortion on subsequent reproduction. Epidemiology Review 4: 66–94, 1982
Holman JF, McGowan JE, Thompson JD. Preoperative antibiotics in major elective gynaecologic surgery. Southern Medical Journal 71: 417–420, 1978
Houang E. Aspects of the vaginal microbial flora. Research and Clinical Forums 6: 7–10, 1984
Houang E, Watson C, Howell R, Chapman M. Ampicillin combined with sulbactam or metronidazole for single-dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy 14: 529–535, 1984
Houang E, Worth R. Piperacillin: as a single dose prophylactic agent in hysterectomies. Journal of Chemotherapy 1: 1027–1028, 1989
Ireland D, Tacchi D, Bint A. Effect of single-dose prophylactic co-trimoxazole on the incidence of gynaecological postoperative urinary tract infections. British Journal of Obstetrics and Gynaecology 89: 578–580, 1982
Jackson P, Ridley WJ, Pattison NS. Single dose metronidazole prophylaxis in gynaecological surgery. New Zealand Medical Journal 89: 243–245, 1979
Jennings H. Prophylactic antibiotics in vaginal and abdominal hysterectomies. Southern Medical Journal 71: 251–254, 1978
Joint Study of the Royal College of General Practitioners and the Royal College of Obstetricians and Gynaecologists. Induced abortion operations and their early sequelae. Journal of the Royal College of General Practitioners 35: 175–180, 1985
Kaiser AB, Herrington Jr JL, Jacom JK, Mulherin Jr JL, Roach AC, et al. Cefoxitin versus erythromycin, neomycin and cefazolin in colerectal operations: importance of the duration of the surgical procedure. Annals of Surgery 198: 525–530, 1983
Krohn K. Investigation of the prophylactic effect of tinidazole on the postoperative infection rate of patients undergoing vacuum aspiration. Scandinavian Journal of Infectious Diseases (Suppl. 26): 101–103, 1981
Ledger W, Gee C, Lewis W. Guidelines for antibiotic prophylaxis in gynecology. American Journal of Obstetrics and Gynecology 121: 1038–1045, 1975
Ledger W, Sweet RL, Hezdington J. Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics and Gynecology 115: 766–774, 1973
Lett WJ, Ansbacker R, Davison BL, Otterson WN, Acosta M, et al. Prophylactic antibiotics for women undergoing vaginal hysterectomy. Journal of Reproductive Medicine 19: 51–54, 1977
Levallois P, Rioux J. Prophylactic antibiotics for suction curettage abortion: results of a clinically controlled trial. American Journal of Obstetrics and Gynecology 158: 100–105, 1988
London RS, London ED, Siegelbaum M, Goldstein P. Use of doxycycline in elective first trimester abortion. Southern Medical Journal 71: 672–673, 1978
MacKenzie I, Fry A. Postabortion sepsis and antibiotic prophylaxis. British Medical Journal 282: 446–447, 1981
Maki DG, Lammers JL, Aughey DR. Comparative studies of multiple-dose cefoxitin vs single-dose cefonicid for surgical prophylaxis in patients undergoing biliary tract operations or hysterectomy. Review of Infectious Diseases 6: S887–S895, 1984
Mathews D, Agarwal V, Gordon AM, Cooper J. A double-blind trial of single dose chemoprophylaxis with co-trimoxazole during vaginal hysterectomy and repair. Journal of Obstetrics and Gynaecology 86: 737–740, 1979
Mathews D, Ross H, Cooper J. A double-blind trial of single-dose chemoprophylaxis with co-trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics and Gynaecology 84: 894–897, 1977
McDonald PJ, Sanders R, Turnidge J, Hakendorf P, Jolley P, et al. Optimal duration of cefoxitin Petrucco O: optimal duration of cefoxitin prophylaxis in abdominal and vaginal hysterectomy. Drugs 35 (Suppl. 2): 216–220, 1988
McGregor JA. Prophylactic antibiotics unjustified for unselected abortion patients. American Journal of Obstetrics and Gynecology 152: 722–723, 1985
Mendelson J, Portnoy J, De Saint Victor J, Gelfand MM. Effect of single and multi-dose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics and Gynecology 53: 31–35, 1979
Mercer LJ, Murphy HJ, Ismail Hajj S. A comparison of cefonicide and cefoxitin for preventing infections after vaginal hysterectomy. Journal of Reproductive Medicine 33: 223–226, 1988
Miles AA, Niven J. Enhancement of infection during shock produced by bacterial toxins and other agents. British Journal of Experimental Pathology 31: 73–95, 1950
Mills AM. An assessment of pre-operative microbial screening on the prevention of post-abortion pelvic inflammatory disease. British Journal of Obstetrics and Gynaecology 91: 182–186, 1984
Moller BR, Ahrons S, Laurin J, Mardh P. Pelvic infection after elective abortion associated with chlamydia trachomatis. Obstetrics and Gynecology 59: 210–213, 1982
Morton K, Regan L, Spring J, Houang E. A further look at infection at the time of therapeutic abortion. European Journal of Obstetrics, Gynecology and Reproductive Biology 37: 231–236, 1990
Munck AM, Jensen HK. Preoperative clindamycin treatment and vaginal drainage in hysterectomy. Acta Obstetricia et Gynecologica Scandinavica 68(3): 241–245, 1989
Ohm MJ, Galask RPL. The effect of antibiotic prophylaxis on patients undergoing total abdominal hysterectomy: the effect on morbidity. American Journal of Obstetrics and Gynecology 125: 442–447, 1976a
Ohm MJ, Galask R. The effect of antibiotic prophylaxis on patients undergoing total abdominal hysterectomy: alterations of microbial flora. American Journal of Obstetrics and Gynecology 125: 448–545, 1976b
Orr JW, Sisson PF, Barrett JM, Ellington JR, Jennings RH, et al. Single-centre study results of cefotetan and cefoxitin prophylaxis for abdominal or vaginal hysterectomy. American Journal of Obstetrics and Gynecology 158: 714–716, 1988a
Orr JW, Sisson PF, Barrett JM, Ellington J, Jennings R, et al. Pharmacokinetics and tissue kinetics of 1gm cefotetan prophylaxis in abdominal or vaginal hysterectomy. American Journal of Obstetrics and Gynecology 158: 742–743, 1988b
Osborne NG, Wright RC, Grubin L. Genital bacteriology: a comparative study of premenopausal women with postmenopausal women. American Journal of Obstetrics and Gynecology 135: 195–198, 1979
Osser S, Persson K. Postabortal pelvic infection associated with Chlamydia trachomatis and the influence of humoral immunity. American Journal of Obstetrics and Gynecology 150: 699–703, 1984
Park TK, Flock M, Schulz KF, Grimes DA. Preventing febrile complications of suction curettage abortion. American Journal of Obstetrics and Gynecology 152: 252–255, 1985
Periti P, Mazzie T, Orlandini F, Mini E. Comparison of the antimicrobial prophylactic efficacy of cefotaxime and cephazolin in obstetric and gynaecological surgery. Drugs 35 (Suppl. 2): 133–138, 1988
Pitkin RM. Abdominal hysterectomy in obese women. Surgery, Gynecology and Obstetrics 142: 532–536, 1976
Polk BF. Antimicrobial prophylaxis to prevent mixed bacterial infection. Journal of Antimicrobial Chemotherapy 8 (Suppl. D): 115–129, 1981
Polk B, Tager I, Shapiro M, Goren-White B, Goldstein P, et al. Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet 1: 437–441, 1980
Qvigstad E, Skaug K, Jerve F, Filing P, Ustrup JC. Pelvic inflammatory disease associated with chlamydia trachomatis infection after therapeutic abortion. British Journal of Venereal Diseases 59: 189–192, 1983
Regallo M, Scalambrino S, Negri I, Landoni F, Mangioni C. Cefotetan versus piperacillin in the prophylaxis of abdominal and vaginal hysterectomy: a prospective randomized study. Drugs Under Experimental and Clinical Research 15(6–7): 315–320, 1989
Ridgway GL, Mumtaz G, Oriel JD. Therapeutic abortion and chlamydial infection. British Medical Journal 286: 1478–1479, 1983
Roberts J, Homesley J. Low-dose carbenicillin prophylaxis for vaginal and abdominal hysterectomy. Obstetrics and Gynecology 52: 83–87, 1978
Roy S, Wilkins J. Single-dose cefotaxime versus 3 to 5 dose cefoxitin for prophylaxis of vaginal or abdominal hysterectomy. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 217–221, 1984
Shapiro M, Munoz A, Tager IB, Schoenbaum SC, Polk BF. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. New England Journal of Medicine 307: 1661–1666, 1982
Shapiro M, Schoenbaum S, Tager I, Munoz A, Polk F. Benefitcost analysis of antimicrobial prophylaxis in abdominal and vaginal hysterectomy. Journal of the American Medical Association 249: 1290–1294, 1983
Sonne-Holm S, Heisterberg L, Hebjorn S, Dyring-Andersen K, Andersen J, et al. Prophylactic antibiotics in first trimester abortions: a clinical controlled trial. American Journal of Obstetrics and Gynecology 139: 693–696, 1981
Swartz W. Prophylaxis of minor febrile and major infectious morbidity following hysterectomy. Obstetrics and Gynecology 54: 284–288, 1979
Swartz WH, Tanaree P. T-tube suction drainage and/or prophylactic antibiotics: a randomized study of 451 hysterectomies. Obstetrics and Gynecology 47: 665–670, 1976
Thadepalli H, Gorbach SL, Keith L. Anaerobic infections of the female genital tract: bacteriologic and therapeutic aspects. American Journal of Obstetrics and Gynecology 117: 1034–1040, 1973
Van-Nagell Jr JR, Rodick J, Cooper R, Triplett H. Vaginal hysterectomy following conization in the treatment of carcinoma in situ of the cervix. American Journal of Obstetrics and Gynecology 113: 948–951, 1972
Walker EM, Hare MJ. Prophylactic single-dose metronidazole before abdominal hysterectomy. British Journal of Obstetrics and Gynaecology 89: 957–961, 1982
Westergaard L, Phlipsen T, Scheibel J. Significance of cervical chlamydia trachomatis infection in postabortal pelvic inflammatory disease. Obstetrics and Gynecology 60: 322–324, 1982
Westrom L, Svensson L, Wolner-Hanssen PL, Mardh PH. A clinical double-blind study on the effect of prophylactically administered single-dose tinidazole on the occurrence of endometritis after first trimester legal abortion. Scandinavian Journal of Infectious Diseases 26: S104–S109, 1981
White RL, Nightingale GH, Quintiliani R, Whitaker K, Jones III R, et al. Serum and tissue concentrations of cefoxitin and cefotaxime in women undergoing hysterectomy. Drugs 35 (Suppl. 2): 72–77, 1988
Wijma J, Kauer FM, van Saene HKF, van de Wiel HBM, Janssens J. Antibiotics and suction drainage as prophylaxis in vaginal and abdominal hysterectomy. Obstetrics and Gynecology 70: 384–388, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Houang, E.T. Antibiotic Prophylaxis in Hysterectomy and Induced Abortion. Drugs 41, 19–37 (1991). https://doi.org/10.2165/00003495-199141010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199141010-00003